Mahdi Tarhini

Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)

Ghada Kchour, Mahdi Tarhini, Hiba El Hajj et al. · Blood · 2009 · 188 citations · Full text

Medicine, Hematology, Pharmacology +11

Zidovudine and interferon-α treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran

Ghada Kchour, Nadine J. Makhoul, Mahmoud Mahmoudi et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 48 citations

Medicine, Hematology, Pharmacotherapy +9

The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia lymphoma

Ghada Kchour, Reza Farid, Akram Ghantous et al. · Retrovirology · 2013 · 45 citations · Full text

Life Sciences, Hematology, Immunology +17

First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy

Mahdi Tarhini, Mohammad Fayyad‐Kazan, Hussein Fayyad‐Kazan et al. · Microbial Pathogenesis · 2018 · 15 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

Increased microvessel density in involved organs from patients with HTLV-I associated adult T cell leukemia lymphoma

Ghada Kchour, Mahdi Tarhini, Nourieh Sharifi et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 13 citations

Medicine, Hematology, Pathology +15